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Abstract: Clostridium perfringens iota-toxin is composed of the enzyme component (Ia) 
and the binding component (Ib). Ib binds to receptor on targeted cells and translocates Ia 
into the cytosol of the cells. Ia ADP-ribosylates actin, resulting in cell rounding and death. 
Comparisons of the deduced amino acid sequence from the gene and three-dimensional 
structure of Ia with those of ADP-ribosylating toxins (ARTs) suggests that there is striking 
structural similarity among these toxins. Our objectives are to review the recent advances 
in the character, structure-function, and the mode of action of iota-toxin by consideration of 
the findings about ARTs. 
Keywords:   Clostridium perfringens;  iota-toxin;  ADP-ribosylating   toxin; 
NAD
+-glycohydrolase; ADP-ribosyltransferase; crystal structure; SN1 mechanism; 
internalization; endocytosis 
 
1. Introduction 
Clostridium perfringens  is rod-shaped and gram positive. The microorganism is an anaerobic 
bacterium, but not a strict anaerobe. Strains of C. perfringens produce four major protein toxins, called 
alpha-, beta-, epsilon- and iota-toxins, which possess lethal and dermonecrotic activities at least, and 
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are classified into five groups (type A to E) [1–3]. C. perfringens  type E, which produces alpha- and 
iota-toxins, causes antibiotic-associated enterotoxemia in rabbits, and is also implicated in sporadic 
outbreaks among calves as well as lambs [4]. C. spiroforme iota-like toxin is reported to be closely 
related to enteritis in rabbits [4]. Therefore, iota-toxin is highly likely to an important agent of 
enterotoxemia caused by C. perfringens type E. 
Iota-toxin composed of an enzyme component (Ia) and a binding component (Ib) is a member of the 
binary toxin group [2,3,5,6] (Tables 1 and 2). Significant progress has been made in the 
characterization of iota-toxin [5]. In addition, information on the biological properties, 
structure-function and mode of action of iota-toxin also has been accumulated [5]. This article 
summarizes current findings and deals with the mechanism of iota-toxin. 
Table 1. Characterization of Clostridium perfringens iota-toxin. 
  Molecular  weight Iota  a (Ia)    47,605 Da (413 residues) 
     Iota  b  (Ib)    74,147  Da  (664  residues) 
    Biological activity  Lethality, Dermonecrosis, Cytotoxicity 
    Enzymatic activity of Ia  NAD
+-glycohydrolase (NADase) 
     ADP-ribosyltransferase  (ARTase)
 
 
Table 2. Structural organization of the binary toxin family. 
  Toxin         Enzymatic  component     Binding  component 
C. perfringens  Iota-toxin   Ia             Ib 
B. anthracis  Toxin      Lethal  factor        Protective  antigen    
                        E d e m a   f a c t o r           
C. botulinum  C 2 t o x i n         C 2 I                      C 2 I I  
C. spiroforme Iota-like  toxin  Sa     Sb     
2. Characteristics of Iota-Toxin 
C. perfringens iota-toxin was initially described by Bosworth in 1943 [7]. Later, the iota toxin was 
found to consist of two components [8], encoded by two genes in a plasmid, organized in an operon [9]. 
Two genes, with the same orientation, coding for Ia (454 amino acids) and Ib (875 amino acids) and 
separated by 243 noncoding nucleotides, were identified. It was reported that a predicted signal peptide 
(41 amino acids) and propeptide (13 amino acids) are missing from Ia and a predicted signal peptide 
(39 amino acids) and propeptide (211 amino acids) are missing from Ib [10], suggesting that the active 
Ia and Ib are composed of 400 and 664 amino acid residues, respectively. Alone, each component is 
nontoxic, but together, Ia and Ib are cytotoxic to various cultured cells, lethal to mice and 
dermonecrotic in guinea pigs [1,2,11] (Table 1). 
Ia ADP-ribosylates skeletal muscle α-actin and nonmuscle β/γ-actin [2,3] (Figure 1). 
ADP-ribosylating toxins facilitate scission of the N-glycosyl bond between nicotinamide and the 
N-ribose of NAD (NAD
+-glycohydrolase, NADase) and transfer the ADP-ribose moiety to target Toxins 2009, 1  
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proteins (ADP-ribosyltransferase, ARTase) [5]. ADP-ribosylating toxins are classified into four 
families (Types I to IV) based on their respective targets [12,13] (Figure 2). Type I targets heteromeric 
GTP-binding proteins, and includes cholera toxin (CT) [14], pertussis toxin (PT) [15], and Escherichia 
coli heat-labile enterotoxin (LT) [16]. Type II [diphtheria toxin (DT) [17] and Pseudomonas exotoxin 
A (ETA) [18]] modifies elongation factor 2 (EF-2). Type III [C. botulinum  C3 exoenzyme] 
ADP-ribosylates small GTP-binding proteins [19]. Type IV ADP-ribosylates actin [5]. Ia belongs to 
Type IV. Iota-toxin is a member of the binary toxin group, which includes C. botulinum C2 toxin (C2I 
and C2II) [20], C. difficile ADP-ribosyltransferase (CDTa and CDTb) [21], C. spiroforme toxin (Sa 
and Sb) [22] and Bacillus cereus vegetative insecticidal protein (VIP) [5]. The enzyme components of 
these toxins, which are structurally similar to Ia, are organized according to the classic A–B model. 
Figure 1. ADP-ribosylating activity of Ia. 
 
Figure 2. A family of bacterial ADP-ribosylating toxins. 
 
Ib displays significant homology with the protective antigen (PA) of anthrax toxins (54.4% 
similarity overall) and C2II (39.0% similarity overall) [5] (Figure 3). The binding components of 
iota-toxin, anthrax toxin and C2 toxin similarly bind to receptors on membranes and interact with the 
enzyme components, mediating their entry into target cells, suggesting that they have a similar mode Toxins 2009, 1  
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of action. As shown in Figure 3, the numbers reveal good homology in domains I, II and III forming 
the pore. In contrast, the homology in the receptor-binding domain IV is negligible among members of 
this group, which can be explained by the receptor-specificity of domain IV [5]. Therefore, the binding 
components of these binary toxins structurally seem to be conserved.   
Furthermore, Richard et al. reported that iota-toxin applied apically or basolaterally induces a rapid 
decrease in the transepithelial resistance (TER) of monolayers of CaCo-2 cells and disorganization of 
actin filaments as well as the tight and adherens junctions [23]. Treatment of Vero cells with iota toxin 
resulted in delayed caspase-dependent death. Unmodified actin did not reappear in toxin-treated cells, 
and Ia was detectable in the cytosol [24]. PA and C2II bind to receptors on cells and interact with 
edema factor or lethal factor and C2I, respectively, mediating entry into target cells [5]. Ib also binds 
to a receptor, interacts with Ia and transfers Ia into the cytosol. The activity of iota-toxin severely 
reduces the ability of actin to undergo polymerization, leading to disruption of the cytoskeletal 
architecture and cell death [5]. 
Figure 3. Comparison of amino acid sequence homology between Ib and PA or C2II. 
 
3. Structure and Function 
Bacterial ADP-ribosylating toxins have been studied as agents that contribute to the pathogenesis of 
bacteria. Domenighini and Rappouli [25] classified ADP-ribosylating toxins into a CT group and a DT 
group, on the basis of amino acid sequences involved in the formation of the NAD-binding site and 
expected to play a role in the activity or in the folding of the proteins. In addition, the two groups do 
not share any detectable sequence homology. 
Analysis of the LT crystal suggested that the nicotinamide ring of NAD
+ docks into the cavity [25]. 
ADP-ribosylating toxins of the CT group including LT, PT, B. sphaericus mosquitocidal toxin (MTX) Toxins 2009, 1  
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[26], ExoS and C3 are known to contain three conserved regions, aromatic residue-R/H, E-X-E, and 
hydrophobic residue-S-T-S-hydrophobic residue, in the cavity formed by the β/α motif [25] (Figure 4). 
The role of these regions had been thought to be as follows. The polar side chains of E-X-E extend 
toward the catalytic cavity and are the common sequence involved in forming the NAD
+ cleft, an 
aromatic residue-R/H located deep in the cavity binds NAD
+, and the S-T-S consensus sequence is 
folded in a β strand representing the floor of the cavity [25]. Glu-378 and -380 in Ia are included 
within the E-X-E sequence essential for the enzymatic activity of CT, LT, and ExoS. Arg-295 is 
present in the aromatic residue-R/H sequence. Ser-338, Ser-340, and Thr-339 are present in the S-T-S 
consensus sequence [25]. A comparison of the amino acid sequence of Ia with sequences of these 
ADP-ribosylating toxins confirmed the existence of these motifs in Ia, showing that Ia belongs to the 
CT group. 
Figure 4. Conserved regions in ADP-ribosylating toxins. 
 
Replacement of Arg-295 with alanine in Ia led to a complete loss of NADase, ARTase, lethal, and 
cytotoxic activities [27]. Perelle et al.  [28] also reported that this residue is essential for 
ADP-ribosylating activity. Thus, it appears that the Arg-295 of Ia is equivalent to the Arg-7 of LT and 
Arg-299 of C2 toxin, which are required for ADP-ribosylating activity [29,30]. Replacement of 
Arg-295 with a basic amino acid such as histidine or lysine also caused a drastic reduction in NADase 
and/or ARTase activities, showing that Arg-295 can not be substituted with other basic residues. 
Therefore, it is apparent that the side chain of Arg-295 is essential for the NADase and ARTase 
activities of Ia [27]. Substitution of Arg-295 with lysine in Ia resulted in a significant reduction in the 
Km for NAD
+, markedly reduced the kcat values for NADase and ARTase, but had little effect on the 
Km for actin [27]. Accordingly, these observations suggest that Arg-295 plays an essential role in the 
binding of Ia to NAD
+. 
Substitution of Glu-378 within the E-X-E sequence with alanine in Ia resulted in a complete loss of 
NADase and ARTase activities [27], as reported by Perelle et al.  [28]; however, conservative 
substitution of Glu-378 with aspartic acid resulted in little effect on NADase activity, and a drastic 
reduction in ARTase activity. These results indicate that Glu-378 plays an important role in ARTase 
activity, but not in NADase activity. It therefore is likely that the carboxyl group of the side chain in Toxins 2009, 1  
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the amino acid at position 378 is not required for NADase activity, but is essential for ARTase activity. 
Barth et al. [29] and Radke et al. [31] found that Glu-378 within the E-X-E motif (Glu378-X-Glu379) 
of C2 toxin and Glu-379 within the motif Glu379-X-Glu381 of ExoS were essential for ARTase 
activity, but not required for NADase activity. Our results support these findings. A kinetic analysis 
showed that replacement of Glu-378 with aspartic acid resulted in a severe reduction in the kcat values 
for ARTase activity, but had little effect on the Km values for NAD
+ and actin, suggesting that the 
residue plays an important role in the catalytic mechanism. The glutamic acid at position 380 within 
the E-X-E sequence was replaced with aspartic acid  and glutamine. The result shows that a 
conservative substitution, such as reduction of the carboxyl group at position 380 by one methylene 
unit or replacement of the carboxyl group by an uncharged amide, simultaneously resulted in a drastic 
reduction in NADase and ARTase activities. Furthermore, replacement of Glu-378 and Glu-380 with 
aspartic acid resulted in little effect on NADase activity and a drastic reduction in ARTase activity, 
respectively suggesting that Glu-380 is essential for the catalytic mechanism of ARTase. Thus, the role 
of Glu-380 in Ia appears to be equivalent to that of the corresponding residues in C2 toxin and LT [27]. 
Damme et al. [32] reported the Glu-378 in Ia was photolabeled by NAD
+, but that Glu-380 was not. 
Therefore, the Glu-378 and -380 residues seem to play different roles in the ADP-ribosylating activity 
of Ia.  
Cieplak et al. [33] reported that substitution of Glu-112 (E110-X-E112) in LT resulted in a marked 
reduction in ARTase activity, suggesting that the residue plays a specific role in the mechanism of 
ADP-ribosylation and represents an essential catalytic residue. In addition, they suggested that 
Glu-110 is unlikely to play a specific role in the reaction mechanism. Hara et al. [34] reported that rat 
T-cell antigen RT 6.1 (Q207-X-E209) catalyzes NADase, but not transfer of the ADP-ribosyl moiety 
and that a mutant RT 6.1 in which Gln-207 was replaced with glutamic acid exhibited ARTase activity. 
Our result is consistent with their findings in that the first glutamic acid residue in the E-X-E motif is 
essential for ARTase activity, but not for NADase activity [27]. However, C3 and EDIN in the ADP 
ribosyltransferase family, which ADP-ribosylates small GTP binding proteins of the rho family, have a 
glutamine residue in the motif, suggesting that the residue in C3 and EDIN which correspond to the 
residue at position 380 in Ia is not required for ARTase activity [35]. Thus, the residue in the motif 
may depend on the substrate. 
The replacement of Ser-338 with alanine or cysteine was not entirely effective, suggesting that the 
hydroxyl group of Ser-338 is not essential for these activities [27]. Furthermore, the substitution of 
Ser-338 with amino acids having a large side chain completely disturbed the ARTase activity. Thus, 
Ser-338 may be extremely close to the catalytic site. Barth et al. [29] reported that Ser-348 in the motif 
S348-T-S350 in C2 toxin plays an essential role in NAD
+- binding or catalysis. There is no 
discrepancy between our results and their model. Replacement of Thr-339 or Ser-340 with alanine 
resulted in a significant but not severe reduction in NADase and ARTase activities. Replacement of 
Thr-339 and Ser-340 did not result in a marked reduction in the Km and kcat values for NADase or 
ARTase, compared with that of Ser-338. Therefore, it is possible that these residues do not play an 
important role in binding and catalytic reactions [27]. Toxins 2009, 1  
 
 
 
214
These observations indicate that Ia has both NADase and ARTase activities; the former transfers 
the ADP ribose moiety to a water molecule, and the latter transfers the moiety to actin [5]. Thus, it 
seems that Arg-298 and Glu-380, required for these activities in Ia, play an important role in the 
cleavage of the N-glycosidic bond of NAD
+ and that Glu-378, required for ARTase activity, but not for 
NADase activity, is essential for the transfer of the ADP-ribose moiety to actin, confirming that Ia 
belongs to the CT group in the ADP-ribosylating enzyme family, not the DT group [27] (Figure 5). 
Figure 5. Amino acid residues at the active site of Ia. 
 
The crystal structure of PA [36] and C2II [37] similarly reveals four domains in these components. 
Gupta et al. [38] suggested that Ca
2+ plays a role in maintaining the conformation of PA, based on an 
analysis of the relationship between Ca
2+ and PA. Gao-Sheridan et al. [39] reported that the bound 
Ca
2+ in PA plays a role in maintaining the conformation of an N-terminal region designated domain I 
which allows PA63 to oligomerize and bind to the enzyme components. It also is speculated that the 
N-terminal region of the binding component has five conserved Asp residues and one conserved Glu 
residue whose side-chain carboxyl groups chelate two calcium ions (Ca
2+-binding motif) [40]  
(Figure 6). It was reported that the N and C termini in the binding components represent the docking 
site for the enzyme component and the binding site for the cell, respectively [5]. We reported that Ib 
binds to a receptor on MDCK cells, forms a heptamer, and then the oligomer is internalized via 
endocytosis [41]. The replacement with alanine of Asp-8, -10 and -12, which are included within the 
conserved motif in Ib, led to a severe reduction in cytotoxic activity [42]. The internalization of these 
variants in cells without Ia resembled that of wild-type Ib alone [42]. We also reported that Ia bound to Toxins 2009, 1  
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Ib in lipid rafts is internalized by endocytosis [43]. However, Ia is not internalized in the cells in the 
presence of D8A, D10A and D12A, suggesting that the Ca
2+-binding motif of Ib has an important role 
in the interaction of Ia in the presence of Ca
2+ [42]. Gao-Sheridin et al. [39] reported that Ca
2+ within 
domain I of PA is required for PA63 subunit–subunit interactions. Gupta et al. [38] speculated on the 
basis of the replacement of amino acid residues in the Ca
2+-binding motif of domain I of PA, that the 
motif is critical for initial protein assembly. However, substitutions at Asp-8, -10 and -12 in Ib resulted 
in about half as much oligomer in cell membranes, indicating that the residues in the Ca
2+- binding 
motif of Ib did not greatly affect the oligomerization of Ib [42]. 
Figure 6. Amino acid sequence in the region containing the calcium-binding motif in 
members of the binary toxin family. 
 
We solved the crystal structure of Ia with NADH, which acts as a inhibitor of the enzymatic activity 
of Ia, at a resolution of 1.8 Å [44,45]. The 411 amino acid residues of Ia were folded into a mixed α/β 
structure of dimensions 68 Å × 50 Å × 47 Å. The enzyme is divided into two domains, the N-domain 
(residues 3–210) and the C-domain (residues 211–413) (Figure 7A). These domains are structurally 
similar despite limited sequence identity. Each domain consists of a β-sandwich core formed by a 
five-stranded mixed β-sheet (β1, β4, β8, β7, and β2 in the N-domain; β9, β12, β16, β15, and β10 in 
the C-domain) and a three stranded anti-parallel β-sheet (β3, β6, and β5 in the N-domain and β11, β14, 
and β13 in the C-domain) (Figure 7B). Around the β-sandwich core, consecutive α-helices (α1, α2, 
α3, α30, and α4 in the N-domain and α6, α7, α8, and α9 in the C-domain) and one additional α-helix 
(α5 in the N-domain and α10 in the C-domain) are arranged. The C-domain has a large cleft, which 
NAD binds, similar to that of the N-domain (Figure 7B). The structure of VIP2 and C2I was solved 
[46,47]. VIP2 and C2I were divided into two domains like Ia. The count of identical residues in these 
enzyme components was 20% in the C-terminal domain and only 10% in the well conserved 
N-terminal domain. However, when Ia was superposed on VIP2, their C-domains were found to be 
quite similar in structure, but not their N-domains. It has been reported that the N-domains of C2I and 
Ia interact with the binding component, C2II and Ib, respectively [5]. Therefore, it is possible that the 
difference in structure of the N-domain reflects the difference in the binding component. It appears that 
the N- and C-domains of these enzyme components play an important role in the binding to substrate 
and the binding component, and catalytic activity, respectively. 
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Figure 7. Structure of Ia. (A) Structure of Ia with NADH (B) The N-domain and C-domain of Ia. 
( A )                                    ( B )  
 
 
The crystal structure of Ia with NADH showed that the nicotinamide ring is clearly identifiable and 
nicotinamide is not cleaved [45,48]. NADH was highly folded in the cavity and formed a ring. As 
shown in Figure 8, N7N of the carboxyamide group on nicotinamide and O1N of the nicotinamide 
mononucleotide moiety (NMN) phosphate formed a hydrogen bond. Arg-295 formed a hydrogen bond 
with O1A of NADH. The Nη1 and Nη2 atoms of Arg-352 formed hydrogen bonds with O1N and 
O2N of NADH, respectively. Oε2 of Glu-380 formed a hydrogen bond with O2’N of the nicotinamide 
ribose in the NMN. All of these hydrogen bonds appear important in making the NMN conformation 
compact and ring-like [45,48]. 
Residues located near the NADH-binding site in the C-domain of Ia have structural similarity to 
those in the C-domain of VIP. Tyr-246, Tyr-251, Asn-255, Arg-295, Glu-301, Ser-338, Phe-349, 
Arg-352, Glu-378, and Glu-380 in Ia are conserved, compared with those in VIP. A kinetic analysis of 
amino acid residues in the cavity showed that Tyr-251, Phe-349 and Arg-352 in Ia are required for 
binding to NAD
+ [45,48]. Thus, they are considered essential for ADP-ribosylating activity. One 
difference in the catalytic C-domain between Ia and VIP2 is in the occluding loop (372–380) that 
overlaps the so-called ARTT motif (373-PGYAGEYE-380), which includes the EXE motif (Glu-378 
and Glu-380). Glu-378 and Glu-380 on the loop play an essential role in the catalytic activity of 
ADP-ribosylation [27], as mentioned above. While Glu-380 in Ia had the same conformation as that in 
VIP2, the orientation of Glu-378 located on the flexible loop differed between Ia and VIP2. 
Furthermore, NAD
+-induced conformational change of the ARTT motif was seen in C3 toxin, which 
ADP-ribosylates Rho [49,50]. Therefore, it is likely that the ARTT motif is important for recognition 
of substrates. 
 
 Toxins 2009, 1  
 
 
 
217
Figure 8. Distance between amino acid residues of the C-domain of Ia and NADH. 
 
When the C-domain of Ia was superimposed on that of DT, the β-sheet fitted that of DT well, but 
the α-helical part fitted less well, and amino acid residues in the catalytic site of Ia were superposed on 
those of DT [48]. Therefore, it appeared that Arg-295, Glu-380 and Phe-349 in Ia are arranged almost 
identically to His-21, Glu-148 and Tyr-65 in DT, and the STS motif near the folded NAD
+ in Ia is 
replaced by a YST sequence in DT [45,48]. From these findings it is concluded that toxins with 
ADP-ribosylating activity have a common basic tertiary structure consisting of a β-sandwich. 
We reported the crystal structure of Ia-actin in a complex with the nonhydrolyzable NAD analog 
βTAD, at a resolution of 2.8 Å [51] (Figure 9). Arg-177 and Asp-179 in G-actin are in close proximity 
to βTAD and Glu-378 of Ia. The shape of bound βTAD is similar to that of NADH, which assumes an 
NMN ring-like conformation. The structure indicated that Ia recognized actin via five loops around 
NAD
+: loop I (Tyr-60–Tyr-62), loop II (active-site loop), loop III, loop IV (PN loop), and loop V 
(ADP-ribosylating turn–turn loop) (Figure 10 and 11). Furthermore, Glu-378 in the EXE is in close 
proximity to Arg-177 in actin.   
The actin-binding interface of Ia was compared with that of other actin-binding proteins, including 
gelsolin [52], vitamin D-binding protein [53], DNaseI [54], and profilin [55]. DNaseI binds with high 
affinity to subdomains II and IV of actin, whereas the other three proteins bind to subdomains I and III. 
Ia mainly binds to actin through subdomains I, III, and IV, which cover its surface in the region that 
includes Arg-177 (Figure 12). The structure of the actin–Ia–βTAD complex showed that the 
recognition interface of Ia differes from that of other known actin-binding proteins [51]. Toxins 2009, 1  
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Figure 9. Ia-actin-TAD complex. 
 
Figure 10. Sequence alignment of ADP-ribosylating toxins. Red circle: Amino acid 
residues in the expected actin binding region. Blue line: interface between the N and C 
domains. Secondary structure elements are coded as follows, β sheet: yellow bars, 
α helices: magenta bars. 
 Toxins 2009, 1  
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Figure 11. The loops in Ia involved in recognizing actin. Roman numerals (I-V) show the 
five actin-binding loops in Ia. 
 
Figure 12．Comparison of the molecular recognition interface of Ia and actin-binding 
proteins. Actin (green) and Ia (magenta) were shown. 
 
We investigated the role of amino acid residues, Asp-61, Tyr-62, Arg-248, Tyr-306 and Tyr-311, at 
the interface between Ia and actin [51]. The replacement of Tyr-62 in loop I and Arg-248 in loop II 
with alanine resulted in a drastic reduction of ARTase activity, but not NADase activity. However, the 
replacement of Asp-61 in loop I and Tyr-306 and Tyr-311 in loop III with alanine had little effect on 
ADP-ribosylating activity and cytotoxicity. Deletion of the N domain caused a drastic decrease in Toxins 2009, 1  
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ARTase activity, whereas >80% of the NADase activity was retained, suggesting the N domain of Ia to 
be important for binding to actin. From these results, it was concluded that loops I and II of Ia play an 
important in binding to actin. On the other hand, the structure of actin within the complex was 
relatively unchanged from its monomeric form. Furthermore, binding of Ia to actin induced a subtle 
shift of loops II, IV, and V of Ia, suggesting that these loops play an important role in the recognition 
of actin. Therefore, it appears that actin is recognized by loops III, IV and V of Ia through not only 
ionic interaction, but also van der Waals interaction, based on the complementary shape. This feature 
might be common to all type IV ADP-ribosylating toxins that consist of two domains [51]. 
Two different mechanisms could be considered for the ADP-ribosylation of Arg-177 in actin by 
ADP-ribosylating toxins, the SN1- and SN2-reactions [45,46]. The positively charged Arg-295 and 
Arg-352 interact electrostatically with a phosphodiester group of NAD
+ and contribute to the highly 
folded conformation of NMN. The specific conformation appears to induce a shift in equilibrium 
toward the production of oxocarbenium cations from NAD
+. A crystallographic analysis of the 
Ia-actin-βTAD complex showed the distance between NC1 of N-ribose and the guanidyl nitrogen of 
Arg-177 to be > 8 Å (Figure 13A), which might make a direct nucleophilic attack impossible via the 
SN2 reaction. Even if the reaction proceeds via the SN1 mechanism, it is unclear how this distance is 
shortened. Therefore, it appears reasonable that the SN1 reaction occurs via the production of two 
intermediates: an oxocarbenium ion intermediate and a cationic intermediate (Figure 13B) [51]. After 
the oxocarbenium ion intermediate is produced, the NP-NO5 rotation of ADP ribose permits the 
N-ribose access to Arg-177. This second cationic intermediate allows the NC1 of N-ribose to approach 
the guanidyl nitrogen of Arg-177 to within a distance of 3.4 Å. (Figure 13B and C). In this model, 
Asp-179 of actin plays a stabilizing role by making contact with the N-ribose 2’ OH (Figures 12B and C). 
Finally, the nucleophile Arg-177 of actin, which associates with Glu-378 of Ia, attacks NC1 of the 
oxocarbenium ion, leading to ADP-ribosylation. We reported that Tyr-251 binds to actin [45]. The 
structure shows that this residue is in close proximity to Asp-179 of actin. It therefore appears that 
Tyr-251 guides the NP-NO5 rotation to position the N-ribose. Furthermore, Tyr-251 might play a role 
in catching the oxocarbenium ion before it is transferred to the guanidyl nitrogen of Arg-177. 
Interestingly, it is possible that the residues around the N-ribose create a negative environment to 
protect the oxocarbenium cation and to prevent an unfavorable reaction with water; these comprise 
Tyr-246, Tyr-251, Ser-338, Tyr-375, Glu-378, and Glu-380. In addition, there is an open space within 
the interface of the complex, suggesting that it does not prevent reactions with water. The space makes 
it possible to rotate N-ribose, thereby allowing NC1 of the oxocarbenium ion to come sufficiently close 
to react with the guanidyl nitrogen of Arg-177. 
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Figure 13. Mechanism for ADP-ribosylation of actin by Ia. 
 
We propose a SN1 mechanism for the Arg-177 ADP-ribosylation that involves the following three 
steps: generation of the first oxocarbenium intermediate by the cleavage of nicotinamide, rotation to 
form the second cationic intermediate around the NP-NO5 bond through the release of the 
conformational strain, and nucleophilic attack of Arg-177 activated by the interaction with   
Glu-378 [51]. 
4. Mode of Action 
Administration of Ib to mice given anti-Ia antiserum within 120 min after the intravenous injection 
of Ia did not cause death [11]. The result shows that the anti-Ia antiserum reacted with Ia in vivo until 
at least 120 min after the intravenous injection of Ia, suggesting that Ia remains free in the blood 
stream in the absence of Ib. Administration of Ia to mice given anti-Ib antiserum 5 min after the 
injection of Ib resulted in death, indicating that the antiserum was unable to neutralize the activity 
under the conditions. It therefore appears that once it binds to the receptor, Ib proceeds immediately to 
a stage which can no longer be inhibited by the antiserum. These results suggest that Ia binds to the Toxins 2009, 1  
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oligomer of Ib and penetrates the target tissue [11]. Dermonecrosis was observed at the site of injection 
of Ib, but not Ia, when Ia and Ib were injected intradermally at separate sites in guinea pigs. 
Furthermore, the intraperitoneal injection of Ia and Ib after the intradermal injection of Ib and Ia, 
respectively, resulted in dermonecrosis at the site of intradermal injection of Ib, but not the intradermal 
injection of Ia. These results indicate that Ia is free in the blood-stream and Ib binds to a receptor in the 
skin, suggesting the migration of Ia to the site of injection of Ib to be essential to the dermonecrotic 
activity induced by separate injections of the two components [11]. Accordingly, it appears that Ia 
binds to Ib bound to target tissues, resulting in lethal effects and dermonecrosis.   
The receptor-bound PA is reported to be internalized by receptor-mediated endocytosis [56]. Milne 
et al. [57] found that PA formed oligomers during the intoxication of mammalian cells. The Aktories 
group has reported that C2II toxin, which resembles PA, forms an oligomer during intoxication [58]. 
However, it has been reported that Ib possesses no activity [6,9,59]. Knapp et al. reported that Ib 
formed a single-channel in artificial lipid bilayers and Vero cells [60]. Recently, we reported that Ib 
specifically binds to Vero cells and induces the release of K
+ from the cells in a dose- and 
time-dependent manner, showing that Ib forms ion-permeable channels in Vero cells without causing 
death [41]. Therefore, it is apparent that Ib also possesses biological activity. SDS-PAGE revealed that 
the migration of the Ib oligomer formed by incubation of Vero cells with Ib at 37 °C was identical to 
that of the Ib heptamer isolated from the purified Ib preparation, showing that Ib forms an oligomer on 
the cell membrane [41]. The time course of K
＋’s release from the cells treated with Ib coincided with 
that of the oligomer’s formation. On the other hand, when Vero cells were incubated with oligomers 
isolated from the purified Ib preparation, no release of K
+ was detected, rounding of the cells was not 
observed in the presence of Ia, and the oligomers bound to the cells were hydrolyzed by treatment with 
pronase. The oligomer formed from the monomer in membranes of the cells was not hydrolyzed by the 
enzyme. These observations imply that the monomer of Ib binds to the cell and forms a functional 
oligomer in the membrane [41]. 
PA and diphtheria toxin were shown to be translocated into the cytosol from an endosomal 
compartment. C2 toxin was reported to enter cells through receptor-mediated endocytosis [59]. 
Furthermore, Barth et al. [58] reported that C2 toxin is released into the cytosol after acidification of 
the endosomal compartment. Considine and Simpson [59] suggested the internalization of Ib by 
receptor-mediated endocytosis to be essential to the toxicity of iota-toxin. Blocker et al. reported that 
treatment with Ib plus Ia in the presence of bafilomycin, methylamine and ethylamine, which prevents 
acidification of endosomal vesicles, caused no change in cells and, in addition, did not cause 
ADP-ribosylation of actin in the cytosol [61]. Ib was trans-cytosed and permanently exposed on 
surface of the opposite cell or continuously recycled between an endosomal compartment and the cell 
surface [23]. We obtained evidence of the cellular routing of Ib. After Vero cells were treated with 
these inhibitors, Ib induced the release of K
＋from the cells, and the oligomer formed on the cells and 
was inserted into the endosomal membranes. These observations suggest that Ib forms ion-permeable 
channels in the membranes (functional oligomer) and that Ib is endocytosed after binding to the cell in 
the absence of Ia. Toxins 2009, 1  
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Recently, lipid rafts have been reported to act as surface platforms during signal transduction and 
endocytosis [62]. In addition, some toxins [63,64], bacteria [65], and viruses [66] have been shown to 
enter cells via lipid rafts. We investigated whether or not the oligomer of Ib accumulates in lipid rafts 
and Ia bound to the oligomer enters the cell. The monomer of Ib was detected in the Triton 
X-100-soluble and -insoluble fractions, the whole membrane, of cells incubated with Ib at 4 °C, 
suggesting that the receptor of Ib is distributed around cytoplasmic membranes. Thus, it is unlikely 
that the receptor is confined to lipid rafts. The oligomer of Ib was detected in lipid rafts after 
incubation of the washed cells at 37 °C, suggesting that Ib bound to the receptor is gathered in lipid 
rafts, and the oligomer is formed there. In addition, the C-terminal region of Ib (Ib421–664) blocked 
the binding of Ib to the cells, as reported by Marvaud et al. [67], and was detected in lipid rafts from 
MDCK cells. It therefore appears that the C-terminal region of Ib binds to a receptor that is distributed 
over the entire membrane of the cell, that a receptor which is linked with Ib gathers in lipid rafts at 
37 °C, and that Ib forms oligomers in the lipid rafts [43]. The treatment of MDCK cells with MβCD 
reduced the cholesterol content of lipid raft fractions, the binding of Ib to the cells, and the rounding 
activity induced by Ia plus Ib. Therefore, it has been speculated that the functional properties of lipid 
rafts that are relevant to the intracellular trafficking of Ib may be especially susceptible to treatment 
with MβCD. It was reported that the disruption or depletion of membrane-associated cholesterol 
causes major changes in the function and/or distribution of raft-associated membrane components [68]. 
It therefore appears that a function of lipid rafts is to gather Ib so that it forms oligomers and enters 
into cells [43]. 
The internalization of iota-toxin is mediated through lipid rafts (cholesterol-rich microdomains) at 
the plasma membrane, suggesting that the lipid rafts contain all of the components necessary for the 
mediation of the toxin’s endocytosis. Gibert et al. reported that after internalization, it was found that 
iota-toxin was not routed to the Golgi apparatus and translocation of the Ia occurs early endosomes 
[69]. The findings that Ib is concentrated in lipid rafts, where it forms oligomers, and that it induces 
endocytosis have provided useful information on the cytotoxicity induced by bacterial toxins. 
5. Conclusions 
Iota-toxin enters host cells and induces toxicity by exploiting the cell’s endogenous pathways as 
follows (Figure 14). (1) Ib binds to a receptor at plasma membranes, then moves to lipid-rafts and 
forms a heptamer, (2) the N-terminal domain of Ia binds to the Ca
2+-binding motif in the N-terminal 
region of Ib, (3) Ia bound to the Ib oligomer is internalized in cells by receptor-mediated endocytosis, 
(4) the complex of Ia and Ib is transported to the early endosomes, where acidification promotes 
cytosolic entry of Ia, and 5) the C-domain and part of the N-domain of Ia bind to G-actin in the cytosol 
and ADP-ribosylate it, thereby blocking the polymerization of actin, and eventually intoxicating cells. 
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Figure 14. Model for internalization of iota-toxin into cells. 
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